India: +91-40-42023318 | Singapore: +65-31631880
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719


United States Department of Education in an evidence based meta-analysis of various studies conducted over a period of 12 years concluded that students who acquired higher education through online mode performed much better than those in regular class room courses. ( opepd/ppss/reports.html)

view more

The James Lind Legacy

Who was James Lind?

Born in the year 1716 in Edinburgh, James Lind, was the first to introduce control group in clinical research. After completing his schooling, he was apprenticed to a physician in 1731. He worked as a Surgeons mate for 8 years in British Navy and was then promoted to Surgeon in 1747.

During this time, scurvy was a grievous disease for the long voyage sailors across the Atlantic Ocean and the reason for it was unknown. James Lind took a challenge to answer this scientific question and experimented on the effectiveness of dietary supplements like oranges, lemon, cider, vinegar, salt, and garlic to prevent scurvy. He chose patients with symptoms of scurvy which includes bleeding gums, sunken eyes, loss of teeth etc., and came to a conclusion that among all supplements used, citrus fruits showed more efficiency against curing scurvy disease.

The administration of citrus fruits in curing scurvy disease was not accepted during his times. Later on, after his death in 1794, the British Navy recognized his work and adopted the practice of giving citrus fruits to the sailors as a dietary supplement.

Due to the exemplary work in this field, James Lind is often considered as the “Father of Naval Medicine” and the International Clinical Trials Day is celebrated around the world on or near the 20 May each year, to celebrate the day that James Lind started his famous trial on the deadly disease scurvy.

James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook